Last reviewed · How we verify

NCT04545840

Prospective Neodent® Zirconia System Study

Status unknown Last updated 9 November 2023
What this trial tests

trial testing Dental Implants in Jaw, Edentulous in 36 participants. Status unknown.

Timeline
10 September 2020
Primary endpoint
30 September 2023
30 December 2024

Quick facts

Lead sponsorNeodent
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment36
Start date10 September 2020
Primary completion30 September 2023
Estimated completion30 December 2024
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Neodent

Who can join

18 and older, any sex, with Jaw, Edentulous or Jaw, Edentulous, Partially. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Neodent® Zirconia Implant is designed for the treatment of oral endosteal implantation for the functional and aesthetic rehabilitation, allowing for treatment of patients with different bone qualities. The objective of the study is to assess the success and survival rates of implantable devices of the Zirconia System, in order to confirm the long-term safety and clinical performance of implants and abutments of the Zirconia System in daily dental practice setting. Devices will be used according to standard routine in daily practice, according to manufacturer indications in the IFU. Patients will be followed for 36 months after implant placement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dental Implants

Trials testing the same drug.

Other recruiting trials for Jaw, Edentulous

Currently open trials in the same condition.

Other Neodent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04545840.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing